Skip to main content

Reporting Long Term Survival Following Precision Tumor-Targeted Gene Delivery to Advanced Chemotherapy-Resistant Malignancies: An Academic Milestone

Publication ,  Conference
Liu, SY; Chawla, SP; Bruckner, H; Morse, MA; Federman, N; Ignacio, JG; San Juan, F; Manalo, RA; Hall, FL; Gordon, EM
Published in: MOLECULAR THERAPY
April 22, 2019

Duke Scholars

Published In

MOLECULAR THERAPY

EISSN

1525-0024

ISSN

1525-0016

Publication Date

April 22, 2019

Volume

27

Issue

4

Start / End Page

133 / 133

Location

Washington, DC

Publisher

CELL PRESS

Conference Name

22nd Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT)

Related Subject Headings

  • Biotechnology
  • 3206 Medical biotechnology
  • 3202 Clinical sciences
  • 3105 Genetics
  • 11 Medical and Health Sciences
  • 10 Technology
  • 06 Biological Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Liu, S. Y., Chawla, S. P., Bruckner, H., Morse, M. A., Federman, N., Ignacio, J. G., … Gordon, E. M. (2019). Reporting Long Term Survival Following Precision Tumor-Targeted Gene Delivery to Advanced Chemotherapy-Resistant Malignancies: An Academic Milestone. In MOLECULAR THERAPY (Vol. 27, pp. 133–133). Washington, DC: CELL PRESS.
Liu, Seiya Y., Sant P. Chawla, Howard Bruckner, Michael A. Morse, Noah Federman, Jorge G. Ignacio, Filomena San Juan, Roseo A. Manalo, Frederick L. Hall, and Erlinda Maria Gordon. “Reporting Long Term Survival Following Precision Tumor-Targeted Gene Delivery to Advanced Chemotherapy-Resistant Malignancies: An Academic Milestone.” In MOLECULAR THERAPY, 27:133–133. CELL PRESS, 2019.
Liu SY, Chawla SP, Bruckner H, Morse MA, Federman N, Ignacio JG, et al. Reporting Long Term Survival Following Precision Tumor-Targeted Gene Delivery to Advanced Chemotherapy-Resistant Malignancies: An Academic Milestone. In: MOLECULAR THERAPY. CELL PRESS; 2019. p. 133–133.
Liu SY, Chawla SP, Bruckner H, Morse MA, Federman N, Ignacio JG, San Juan F, Manalo RA, Hall FL, Gordon EM. Reporting Long Term Survival Following Precision Tumor-Targeted Gene Delivery to Advanced Chemotherapy-Resistant Malignancies: An Academic Milestone. MOLECULAR THERAPY. CELL PRESS; 2019. p. 133–133.

Published In

MOLECULAR THERAPY

EISSN

1525-0024

ISSN

1525-0016

Publication Date

April 22, 2019

Volume

27

Issue

4

Start / End Page

133 / 133

Location

Washington, DC

Publisher

CELL PRESS

Conference Name

22nd Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT)

Related Subject Headings

  • Biotechnology
  • 3206 Medical biotechnology
  • 3202 Clinical sciences
  • 3105 Genetics
  • 11 Medical and Health Sciences
  • 10 Technology
  • 06 Biological Sciences